首页> 美国卫生研究院文献>JHEP Reports >Approaches for patients with very high MELD scores
【2h】

Approaches for patients with very high MELD scores

机译:MELD分数​​很高的患者的治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the era of the “sickest first” policy, patients with very high model for end-stage liver disease (MELD) scores have been increasingly admitted to the intensive care unit with the expectation that they will receive a liver transplant (LT) in the absence of improvement on supportive therapies. Such patients are often admitted in a context of acute-on-chronic liver failure with extrahepatic failures. Sequential assessment of scores or classification based on organ failures within the first days after admission help to stratify the risk of mortality in this population. Although the prognosis of severely ill cirrhotic patients has recently improved, transplant-free mortality remains high. LT is still the only curative treatment in this population. Yet, the increased relative scarcity of graft resource must be considered alongside the increased risk of losing a graft in the initial postoperative period when performing LT in “too sick to transplant” patients. Variables associated with poor immediate post-LT outcomes have been identified in large studies. Despite this, the performance of scores based on these variables is still insufficient. Consideration of a patient’s comorbidities and frailty is an appealing predictive approach in this population that has proven of great value in many other diseases. So far, local expertise remains the last safeguard to LT. Using this expertise, data are accumulating on favourable post-LT outcomes in very high MELD populations, particularly when LT is performed in a situation of stabilization/improvement of organ failures in selected candidates. The absence of “definitive” contraindications and the control of “dynamic” contraindications allow a “transplantation window” to be defined. This window must be identified swiftly after admission given the poor short-term survival of patients with very high MELD scores. In the absence of any prospect of LT, withdrawal of care could be discussed to ensure respect of patient life, dignity and wishes.
机译:在“病重至上”政策时代,对终末期肝病(MELD)评分非常高的模型的患者越来越多地被接受重症监护病房,以期他们将在接受肝移植(LT)的同时接受肝脏移植(LT)。支持疗法没有改善。此类患者通常因慢性肝功能衰竭伴肝外衰竭而入院。在入院后的头几天内根据器官衰竭进行评分或分类的顺序评估,有助于对该人群的死亡风险进行分层。尽管最近重症肝硬化患者的预后得到了改善,但无移植物的死亡率仍然很高。 LT仍然是该人群中唯一的治疗方法。但是,必须考虑到移植物资源相对稀缺的增加,以及对“病重至无法移植”患者进行LT术后初期初始移植物丢失风险的增加。在大型研究中已经确定了与LT后即刻不良预后相关的变量。尽管如此,基于这些变量的得分表现仍然不足。在这种人群中,考虑患者的合并症和虚弱是一种有吸引力的预测方法,已被证明在许多其他疾病中具有重要价值。到目前为止,本地专业知识仍然是LT的最后保障。利用这些专业知识,可以在非常高的MELD人群中积累有利的LT后结果数据,尤其是在稳定/改善某些候选器官衰竭的情况下进行LT时。缺少“确定性”禁忌症和对“动态”禁忌症的控制允许定义“移植窗口”。考虑到MELD评分很高的患者短期生存期较差,入院后必须迅速确定该窗口。在没有长期护理的前景的情况下,可以讨论撤消护理以确保尊重患者的生命,尊严和愿望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号